642 related articles for article (PubMed ID: 9354928)
21. Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study.
Owonikoko T; Loberg C; Gabbert HE; Sarbia M
J Pathol; 2001 Feb; 193(2):155-61. PubMed ID: 11180160
[TBL] [Abstract][Full Text] [Related]
22. Skin cancer and the sun.
Lyons M
J Pract Nurs; 1982 Jun; 32(6):16-20, 40. PubMed ID: 6920399
[No Abstract] [Full Text] [Related]
23. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
24. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
25. TP53 mutations in human skin cancers.
Giglia-Mari G; Sarasin A
Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
[TBL] [Abstract][Full Text] [Related]
26. [Reasons for the increased incidence of skin cancer].
Ishihara K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1380-5. PubMed ID: 17033224
[TBL] [Abstract][Full Text] [Related]
27. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
28. Epidermal malignant tumors: pathogenesis, influence of UV light and apoptosis.
Massari LP; Kastelan M; Gruber F
Coll Antropol; 2007 Jan; 31 Suppl 1():83-5. PubMed ID: 17469758
[TBL] [Abstract][Full Text] [Related]
29. Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D.
Oberyszyn TM
Cancer Lett; 2008 Mar; 261(2):127-36. PubMed ID: 18267352
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with the development of skin cancer after liver transplantation.
Mithoefer AB; Supran S; Freeman RB
Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
[TBL] [Abstract][Full Text] [Related]
31. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
33. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer.
Rigel DS
J Am Acad Dermatol; 2008 May; 58(5 Suppl 2):S129-32. PubMed ID: 18410798
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
37. Update on the pathogenesis and immunotherapy of esophageal squamous cell carcinoma.
Cervantes J
Rev Gastroenterol Peru; 2004; 24(2):165-70. PubMed ID: 15241495
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study.
Han J; Colditz GA; Hunter DJ
Int J Epidemiol; 2006 Dec; 35(6):1514-21. PubMed ID: 16943234
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
40. Ultraviolet B-induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin.
Sauter ER; Klein-Szanto AJ; Atillasoy E; Montone KT; Goodrow T; Binder RL; Seykora JT; Herlyn M
Mol Carcinog; 1998 Nov; 23(3):168-74. PubMed ID: 9833777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
